Prostate Cancer Market

As per American Cancer Society (2019), “One in Nine men in the United States is diagnosed with prostate cancer at some point in their lives”.

According to DelveInsight’s Prostate Cancer Epidemiological analysis, by 2020, a total of 7,494,882 males will be diagnosed with prostate cancer in the Seven Major Markets, and the United States alone will account for 3,478,728 Prostate Cancer prevalent cases.

At present, several companies have indulged themselves, their time and money in initiating clinical trials investigating the novel treatments options for Prostate Cancer.

Some of the key Companies in Prostate Cancer Market include AstraZeneca/Merck Sharp & Dohme, Bristol-Myers Squibb, Novartis, Myovant Sciences, Janssen Research & Development, Hinova Pharma, Hoffmann-La Roche, Clovis Oncology, Advantagene or Candel Therapeutics, and several others.

For more detailed information visit:
https://www.delveinsight.com/blog/prostate-cancer-market/